20014 ⎘
Medicinal preparations characterised by special physical form; Galenical forms characterised by the drug release technique; Application systems commanded by energy Osmotic delivery systems; Sustained release driven by osmosis, thermal energy or gas
Osmotic delivery systems and piston assemblies for use therein
#602POLYMERIC SYSTEMS FOR CONTROLLED DRUG THERAPY
#603DOSAGE FORM COMPRISING THERAPEUTIC FORMULATION
#604BLOW-MOLDED THIN-WALLED DRUG DELIVERY CAPSULES
#605MODIFIED-RELEASE FORMULATIONS OF AZABICYCLO DERIVATIVES
#606Treatment of amyotrophic lateral sclerosis
#607Hypersaturated gas in liquid
#608OSMOTIC FORM FOR CONTROLLED RELEASE OF ACTIVE PRINCIPLES
#609Medical device with reservoir-based sensors
#610Systems for modulating inflammation
#611GASTRORETENTIVE SYSTEM COMPRISING AN ALGINATE BODY
#612Device and method for examining a body lumen
#613Sustained delivery of an active agent using an implantable system
#614Composition and dosage form comprising a particle formulation and suspending vehicle
#615MICROPOROUS FILM AND PREPARATION AND USE THEREOF
#616OSMOTIC TABLET WITH A COMPRESSED OUTER COATING
#617Abuse-Resistant Dosage Form
#618Methods and devices for providing prolonged drug therapy
#619Highly concentrated drug particles, formulations, suspensions and uses thereof
#620RATIONAL PPI DOSAGE FORMS
#621THERAPEUTIC AGENT FOR SPINAL CORD INJURIES
#622SYSTEMIC DELIVERY OF ANTIVIRAL AGENTS
#623Divisible Osmotic Dosage Forms and Methods of Use
#624POLYETHYLENE GLYCOL LIPID CONJUGATES AND USES THEREOF
#625CONTROLLED RELEASE DOSAGE FORMS OF ZOLPIDEM
#626Methods of treatment using a gastric retained gabapentin dosage
#627Configurations And Methods For Power Generation In LNG Regasification Terminals
#628HYDROMORPHONE THERAPY
#629COMPOSITION AND COMBINATIONS OF CARBOXYLIC ACID LOSARTAN IN DOSAGE FORMS
#630SUSTAINED RELEASE DOSAGE FORMS OF ZIPRASIDONE
#631CONTROLLED RELEASE FORMULATIONS OF PRAMIPEXOLE
#632Pharmaceutical formulation containing a biguanide and an angiotensin antagonist
#633Stable Pharmaceutical Compositions Containing Pravastatin
#634Treatment of Gastroparesis and Nonulcer Dyspepsia With GABAB Agonists
#635Method and process for the production of multi-coated recognitive and releasing systems
#636Method and process for the production of multi-coated recognitive and releasing systems
#637ENHANCED EFFICACY BENZISOXAZOLE DERIVATIVE DOSAGE FORMS AND METHODS
#638Methods of Reducing Alcohol-Induced Dose Dumping for Opioid Sustained Release Oral Dosage Forms
#639Multiple PPI dosage form
#640Pharmaceutical dosage forms comprising an active ingredient combination of nifedipine and/or nisoldipine and an angiotensin II antagonist
#641IMPROVED PHARMACOKINETIC PROFILE OF BETA-ADRENERGIC INVERSE AGONISTS FOR THE TREATMENT OF PULMONARY AIRWAY DISEASES
#642ORAL PHARMACEUTICAL COATED COMPOSITION FOR PULSATILE RELEASE
#643Methods and dosage forms for controlled delivery of paliperidone and risperidone
#644Controlled release hydrocodone formulations
#645Devices, formulations, and methods for delivery of multiple beneficial agents
#646OSMOTIC PUMP WITH AT LEAST ONE CHARGEABLE MATERIAL
#647SYSTEM AND METHOD FOR MANUFACTURING ORAL OSMOTIC DRUG DELIVERY DEVICES, AND METHODS OF ADMINISTERING SAME
#648Methods and apparatus for determining formulation orientation of multi-layered pharmaceutical dosage forms
#649Metal Coordination Complexes Of Volatile Drugs
#650Pharmaceutical safety dosage forms
#651Method of manufacturing modified release dosage forms
#652PHARMACEUTICAL FORMULATIONS OF POTASSIUM ATP CHANNEL OPENERS AND USES THEREOF
#653PHARMACEUTICAL FORMULATIONS OF POTASSIUM ATP CHANNEL OPENERS AND USES THEREOF
#654PHARMACEUTICAL DOSAGE FORMS COMPRISING A LOW-SOLUBILITY DRUG AND A POLYMER
#655Compositions for the Treatment and Prevention of Eyelid Swelling
#656Dosage Form Comprising Therapeutic Formulation
#657Osmotic pump comprising a pressure device for pressurizing the solvent
#658Biodegradable implants with controlled bulk density
#659Extended release compositions of proton pump inhibitors
#660NOVEL CRYSTALLINE FORMS OF CONAZOLES AND METHODS OF MAKING AND USING THE SAME
#661Formulation and dosage form for increasing oral bioavailability of hydrophilic macromolecules
#662Stable, non-aqueous, single-phase gels and formulations thereof for delivery from an implantable device
#663Polymer devices for therapeutic applications
#664Method of inducing a CTL response
#665Method and system for control of osmotic pump device
#666Methods of using cgrp for cardiovascular and renal indications
#667Method and system for control of osmotic pump device
#668Implantable medical device for diagnostic sensing
#669MULTIPARTICULATE OSMOTIC DELIVERY SYSTEM
#670Rupturing controlled release device comprising a subcoat
#671Hydrostatic delivery system for controlled delivery of agent
#672Drug condensation aerosols and kits
#673Polymer Composition And Dosage Forms Comprising The Same
#674Dosage forms for movement disorder treatment
#675Triple combination release multi-layered tablet
#676CONTROLLED RELEASE DOSAGE FORMS COMBINING IMMEDIATE RELEASE AND SUSTAINTED RELEASE OF LOW-SOLUBILITY DRUG
#677Oral Therapeutic Compound Delivery System
#678Treatment of amyotrophic lateral sclerosis
#679Osmotic pump with self-retaining, fast-start membrane plug
#680Osmotically driven dispense pump and related components for use in high pressure applications
#681Formulations with Controlled Release of Active Ingredient
#682Suspension formulations of insulinotropic peptides and uses thereof
#683Bioadhesive Rate-Controlled Oral Dosage Formulations
#684Polymer release system
#685Osmotically-driven fluid dispenser
#686ORAL OSMOTIC DRUG DELIVERY SYSTEM
#687Compositions and methods for inhibiting gastric acid secretion
#688Controlled release coated tablets having prolonged gastric retention
#689Controlled release solid dispersions
#690Macrocyclic lactone compounds and methods for their use
#691Transdermal drug delivery with controlled heat for treating musculoskeletal pain and/or inflammation
#692Method and process for the production of multi-coated recognitive and releasing systems
#693Stable non- aqueous single phase viscous vehicles and formulations utilizing such vehicles
#694METHODS AND DEVICES FOR RENAL NERVE BLOCKING
#695METHOD OF MAKING DOSAGE FORMS COMPRISING POLYMERIC COMPOSITIONS
#696ZERO ORDER CONTROLLED RELEASE COMPOSITIONS OF TIZANIDINE
#697Drug Delivery Formulations For Targeted Delivery
#698Formulations With Controlled Release Of Active Ingredient
#699Dosage Form Comprising Therapeutic Formulation
#700Delivery device containing venlafaxine and memantine and method of use thereof
#701Controlled Release Dosage Form Containing Lercanidipine and a Performance-enhancing Acid
#702Devices and methods for pain management
#703Devices and methods for pain management
#704Controlled release compositions comprising Nimesulide
#705Cotton variety 781000G
#706System and method for manufacturing oral osmotic drug delivery devices, and methods of administering same
#707SYSTEM AND METHOD FOR MANUFACTURING ORAL OSMOTIC DRUG DELIVERY DEVICES, AND METHODS OF ADMINISTERING SAME
#708Dosage Forms Providing Controlled and Immediate Release of Cholesteryl Ester Transfer Protein Inhibitors and Immediate Release of Hmg-Coa Reductase Inhibitors
#709Method for operating a reservoir-based sensor device
#710Method for making reservoir-based sensor device
#711RECOMBINANT EUKARYOTIC CELLS STABLY EXPRESSING (SID-1) PROTEINS FOR HIGH THROUGHPUT GENE SCREENING
#712Composition Comprising Ocaperidone
#713Osmotic pump apparatus and associated methods
#714Glipizide controlled-release composition and method of preparation
#715Nifedipine controlled release compositions and preparation methods therefor
#716Osmotic delivery systems and piston assemblies for use therein
#717Controlled release drug compositions and preparation methods
#718Controlled Long Acting Release Pharmaceutical Preparation For Use In The Oral Cavity
#719Modified release formulations of a bupropion salt
#720Tamsulosin controlled-release tablet
#721Osmotic Delivery System Flow Modulator Apparatus and Method
#722Active Drug Delivery in the Gastrointestinal Tract
#723Injectable sustained release delivery devices
#724Modified release formulations of a bupropion salt
#725Modified release formulations of a bupropion salt
#726PUNCTAL PLUGS FOR THE DELIVERY OF ACTIVE AGENTS
#727Methods and devices for thermal treatment
#728Modified release formulations of a bupropion salt
#729Modified release formulations of a bupropion salt
#730Modified release formulations of a bupropion salt
#731Hot flash treatment system
#732Modified release formulations of a bupropion salt
#733Modified release formulations of a bupropion salt
#734Method for the Management of Incontinence
#735Controlled release formulations of enzymes, microorganisms, and antibodies with mucoadhesive polymers
#736Pharmaceutical Compositions Comprising (+)-(2S,3S)-2-(3-Chlorophenyl)-3,5,5-Trimethyl-2-Morpholinol
#737Device for the controlled exposure of reservoir-based sensors
#738Nanoshells on polymers
#739METHODS OF TREATING CONDITIONS BY SUSTAINED RELEASE ADMINISTRATION OF BENZIMIDAZOLE DERIVATIVES
#740Controlled Release Compositions Comprising Levetiracetam
#741Modified release formulations of a bupropion salt
#742Drug and excipient aerosol compositions
#743Two-piece, internal-channel osmotic delivery system flow modulator
#744MODIFIED RELEASE FORMULATIONS OF A BUPROPION SALT
#745Controlled release devices for fusion of osteal structures
#746Modified release formulations of a bupropion salt
#747Modified release formulations of a bupropion salt
#748Pharmaceutical formulations
#749Controlled release formulations exhibiting an ascending rate of release
#750Osmotic drug delivery system
#751Controlled release devices for therapeutic treatments of spinal discs
#752ASYMMETRIC MEMBRANES FOR DRUG DELIVERY DEVICES
#753NOVEL DRUG COMPOSITIONS AND DOSAGE FORMS OF TOPIRAMATE
#754USE OF PALIPERIDONE FOR THE TREATMENT OF SLEEP DISTURBANCES AND/OR EXCESSIVE DAYTIME SLEEPINESS IN PSYCHIATRIC PATIENTS
#755Formulations including hygroscopic compounds
#756Pharmaceutical formulation containing a biguanide and an angiotensin antagonist
#757Dosage Form for Time-Varying Patterns of Drug Delivery
#758Osmotic Delivery System Having Space Efficient Piston
#759Use of Memantine and Brimonidine to Attenuate Vitreoretinal Vascular Endothelial Growth Factor (VEGF) Protein Levels in Animals
#760METHOD AND APPARATUS FOR SEMI-PERMEABLE MEMBRANE DETECTION ON OSMOTIC TABLETS INCORATING NEAR-INFRARED SPECTROSCOPY
#761METHOD AND APPARATUS FOR DRILLING ORIFICES IN OSMOTIC TABLETS INCORPORATING NEAR-INFRARED SPECTROSCOPY
#762Taste-masked drugs in rupturing multiparticulates
#763Osmotic pump with means for dissipating internal pressure
#764Osmotic dosage form with controlled release and fast release aspects
#765Sustained release dosage forms of ziprasidone
#766Modified release formulations of tramadol and uses thereof
#767Volume Efficient Controlled Release Dosage Form
#768OSMOTIC DOSAGE FORM WITH CONTROLLED RELEASE AND FAST RELEASE ASPECTS
#769Pre-fabricated semi-permeable capsule shells containing a semipermeable layer on a water-dispersible/soluble gelatinous shell for osmotic drug delivery system
#770Drug delivery systems using mesoporous oxide films
#771Controlled release metformin formulations
#772Gastric release pulse system for drug delivery
#773Dosage forms for movement disorder treatment
#774Osmotic pump with remotely controlled osmotic pressure generation
#775Method and system for control of osmotic pump device
#776Osmotic pump with remotely controlled osmotic pressure generation
#777Remote control of osmotic pump device
#778Osmotic pump with remotely controlled osmotic flow rate
#779Composition for releasing a weak base for an extended period of time
#780Oral osmotic drug delivery system
#781Oral osmotic drug delivery system
#782Oral osmotic drug delivery system
#783Oral osmotic drug delivery system
#784Extended release dosage form
#785Pharmaceutical formulations
#786Controlled release compositions comprising nimesulide
#787Drug condensation aerosols and kits
#788Extended release osmo-microsealed formulation
#789Minimally compliant, volume efficient piston for osmotic drug delivery systems
#790Water Soluble and Palatable Complexes
#791Osmotic implant with membrane and membrane retention means
#792Hydrogel-Driven Drug Dosage Form
#793Pharmaceutical form with sustained pH-independent active ingredient release for active ingredients having strong pH-dependent solubility
#794Localized delivery to the lymphatic system
#795Venlafaxine osmotic device formulation
#796Microfabricated nanopore device for sustained release of therapeutic agent
#797Method for reducing risk of and extent of injury due to stroke in hypertensive subjects
#798Pharmaceutical formulations/composition of guanfacine suitable for single dose form administration daily
#799Dosage form comprising liquid formulation
#800Osmotic dosage forms comprising semipermeable membranes with polymer blends providing improved properties
#801Modified release formulations of a bupropion salt
#802Peroxide removal from drug delivery vehicle
#803Pharmaceutical co-crystal compositions
#804Liquid formulations for controlled delivery of benzisoxazole derivatives
#805Solid, modified-release pharmaceutical dosage forms which can be administered orally
#806Thermal effect on crystalinity for drug delivery devices
#807DUAL MEMBRANE ELECTRO-OSMOTIC FLUID DELIVERY DEVICE
#808Method for controlling lag time of in-situ passageway formation in osmotic delivery system
#809Antidepressant dosage form
#810Osmotic Intraosseous Drug Delivery System
#811Methods and dosage forms for reducing side effects of carbamate compounds
#812Semi-permeable compositions providing reduced drying time for osmotic dosage forms
#813Dosage forms for movement disorder treatment
#814Pharmaceutical formulations
#815Pharmaceutical formulations
#816Delivery and formulations of mast cell stabilizers
#817Multi-layer structure having a predetermined layer pattern including an agent
#818Suspension formulation of interferon
#819Combination of tramadol and substances that comprise gabapentin
#820Pharmaceutical formulations of amyloid inhibiting compounds
#821Controlled release formulations of opioid and nonopioid analgesics
#822Pharmaceutical formulations of amyloid inhibiting compounds
#823Implantable device for continuous delivery of interferon
#824Polyoxaester suspending vehicles for use with implantable delivery systems
#825Arthroscopic chondrocyte implantation method and device
#826Osmotic dosage form
#827Device and method for accurate delivery of an active agent
#828Novel olanzapine forms and related methods of treatment
#829Suspending vehicles and pharmaceutical suspensions for drug dosage forms
#830Programmed drug delivery system
#831Dual controlled release dosage form
#832Polymeric systems for controlled drug therapy
#833Solvent/polymer solutions as suspension vehicles
#834Composition and method for treating neurological disease
#835Enhanced efficacy benzisoxazole derivative dosage forms and methods
#836Osmotic delivery system with early zero order push power engine
#837Dosage form and method for sustained release of substituted pyrazine compound
#838Dual controlled release osmotic device
#839Controlled release device containing lercanidipine
#840Medical device and method for diagnostic sensing
#841Oral osmotic dosage form having a high flux membrane
#842Osmotic device containing amantadine and an osmotic salt
#843Method of inducing a CTL response
#844Hot flash treatment system
#845HMG-CoA reductase inhibitor extended release formulation
#846HMG-CoA reductase inhibitor extended release formulation
#847Temperature modulation of transdermal drug delivery
#848Osmotic delivery system having space-efficient piston
#849Osmotic delivery device having a two-way valve and a dynamically self-adjusting flow channel
#850Electro-osmotic fluid delivery device and method
#851Fluid delivery device having an electrochemical pump with an ion-exchange membrane and associated method
#852Minimally compliant, volume-efficient piston for osmotic drug delivery systems
#853Pharmaceutical tablet and process for making thereof
#854Antidepressant dosage form
#855Compositions and dosage forms for enhanced absorption
#856Transdermal therapeutic system suitable for heat application for promoting the permeation of active substances, and the use thereof
#857Delivery device
#858Delivery device containing venlafaxine and memantine and methods of use thereof
#859Controlled release nanoparticle active agent formulation dosage forms and methods
#860Fluid delivery device having an electrochemical pump with an ion-exchange membrane and associated method
#861Pharmaceutical formulations of potassium ATP channel openers and uses thereof
#862Density-matched suspension vehicles and pharmaceutical suspensions
#863Method for preparing a medical solution for the manufacture of a medicament for peritoneal dialysis
#864Controlled release metformin compositions
#865Compositions and methods for preventing abuse of orally administered medications
#866Stable suspension formulations of erythropoietin receptor agonists
#867Neural stimulation device employing renewable chemical stimulation
#868Controlled release metformin compositions
#869Controlled release metformin compositions
#870Controlled release metformin compositions
#871Controlled release metformin compositions
#872Pharmaceutical compositions with synchronized solubilizer release
#873Squeeze controlled oral dosage form
#874Dosage forms for low solubility and or low dissolution rate free acid pharmaceutical agents
#875Oral delivery system comprising a drug/polymer complex
#876Extended release oxybutynin formulation
#877Osmotic delivery system, osmotic delivery system semipermeable body assembly, and method for controlling delivery rate of beneficial agents from osmotic delivery systems
#878Controlled release formulations of enzymes, microorganisms, and antibodies with mucoadhesive polymers
#879Non-aqueous single phase vehicles and formulations utilizing such vehicles
#880Modified release dosage forms
#881Methods and dosage forms for controlled delivery of alprazolam
#882Dosage form for delivery of multiple drug forms
#883Pharmaceutical formulation containing a biguanide and a thiazolidinedione derivative
#884Implantable device, formulation and method for anti-psychotic therapy using risperidone
#885Methods and devices for providing prolonged drug therapy
#886Methods and dosage forms for controlled delivery of paliperidone and risperidone
#887Pain relief composition, method to form same, and method to use same
#888Pharmaceutical formulation containing a biguanide and a thiazolidinedione derivative
#889Dosage forms having a barrier layer to laser ablation
#890Method of treating amyloid beta precursor disorders
#891Abuse-safeguarded dosage form
#892Monocompartment osmotic controlled drug delivery system
#893Methods and dosage forms for reducing side effects of benzisozazole derivatives
#894Method and apparatus treating tissue adjacent a bodily conduit with thermocompression and drugs
#895Bioadhesive polymers with catechol functionality
#896Polymeric compositions and dosage forms comprising the same
#897Polymeric compositions and dosage forms comprising the same
#898Polymeric compositions and dosage forms comprising the same
#899Treating or preventing restless legs syndrome using prodrugs of GABA analogs
#900Abuse-resistant pharmaceutical dosage form